Abstract
An updated review of cases of reactivated visceral leishmaniasis (VL) in transplant patients is presented, with a new report of a kidney transplant patient who had VL caused by reactivation of a dormant infection contracted 21 years previously. Close to the time of disease reactivation, the patient had a primary varicella-zoster infection.
MeSH terms
-
Amphotericin B / therapeutic use
-
Antiprotozoal Agents / therapeutic use
-
Graft Rejection / prevention & control
-
Humans
-
Immunocompromised Host
-
Kidney Transplantation / adverse effects*
-
Kidney Transplantation / immunology
-
Leishmania*
-
Leishmaniasis, Visceral / diagnosis*
-
Leishmaniasis, Visceral / drug therapy
-
Leishmaniasis, Visceral / etiology
-
Male
-
Middle Aged
-
Opportunistic Infections / parasitology*
Substances
-
Antiprotozoal Agents
-
Amphotericin B